Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-22

Clinical Trial Update: In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing in vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASAQ (amodiaquine-artesunate)
  • Coartem (artemether-lumefantrine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: MALARIA, FALCIPARUM | Phase 4 | Status: COMPLETED